US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Defiance Daily Target 2X Long NVO ETF

9.10

-0.0500-0.55%

Pre-market: 8.97-0.1300-1.43%05:13 EDT

Volume:481.22K

Turnover:4.40M

Market Cap:38.11M

PE:- -

High:9.25

Open:9.25

Low:9.04

Close:9.15

52wk High:33.84

52wk Low:9.04

Shares:4.19M

Float Shares:4.19M

Volume Ratio:0.94

T/O Rate:11.49%

Dividend:- -

Dividend Rate:- -

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Patients Switching to Novo Nordisk's Wegovy Pill from Shots Lose More Weight in Real-World Study

2026 Nobel Prize Preview: Scientists Behind GLP-1 Weight-Loss Drugs Emerge as Leading Contenders

Novo Says Ozempic Cuts Risk of Major Cardiovascular Events

Analysts Offer Insights on Healthcare Companies: Novo Nordisk (NVO), ClearPoint Neuro (CLPT) and Axsome Therapeutics (AXSM)

Eli Lilly Reports Zepbound Showed 4.5% Greater Weight Loss Than Novo Nordisk's Wegovy HD

MT Newswires Live

Lilly's Zepbound (Tirzepatide 10 Mg and 15 Mg) was Associated with More Weight Loss than Wegovy Hd (Semaglutide Injection 7.2 Mg) in a New Indirect Treatment Comparison

THOMSON REUTERS

Novo Nordisk Says Ozempic Shows Lower Risk of Cardiovascular Events Compared to Eli Lilly's Mounjaro

Novo Nordisk announces retrospective RWE on Ozempic in type 2 diabets

Novo Nordisk Strikes Second Licensing Deal Since Frosty Capital-Markets Day

China's Hengrui Inks up to $2.6 Billion Deal with Novo Nordisk for Obesity Drug

Hengrui Pharma and Novo Nordisk Sign Licensing Agreement for HRS-1596 Project

Option traders moderately bearish in Novo Nordisk with shares down 0.22%

Novo Nordisk A/S Series B Stock Falls Monday, Outperforms Market

Taking Ozempic? a Routine Eye Exam Could Help You Understand Your Risk for Vision Loss

ETF Weekly | QCML Soars 27%; INTW, AMUU, FBL, AMDL Jump 26%; SOXL Rallies 22%; Semiconductor Longs Lead

Novo Nordisk (0QIU) Receives a Hold from Bank of America Securities

Novo Bets on Next Chapter While Eli Lilly Extends Its GLP-1 Dominance

After Capital-Markets Day Flop, Novo Strikes Licensing Deal That Sends a Swedish Company's Stock Soaring

Novo Nordisk Licenses Nanexa Drug Delivery Technology

MT Newswires Live

Cboe data shows mixed options sentiment in Novo Nordisk with shares up 0.96%

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://hk.tigeractivity.com/stock/NVOX/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"NVOX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NVOX\",,,,,undefined,":{"symbol":"NVOX","market":"US","secType":"STK","nameCN":"Defiance Daily Target 2X Long NVO ETF","latestPrice":9.1,"timestamp":1790971200000,"preClose":9.15,"halted":0,"volume":481216,"hourTrading":{"tag":"盘前","latestPrice":8.97,"preClose":9.1,"latestTime":"05:13 EDT","volume":1960,"amount":17442.32616,"timestamp":1791191590157,"change":-0.13,"changeRate":-0.014286,"amplitude":0.018791},"delay":0,"changeRate":-0.005464480874317017,"floatShares":4188101,"shares":4188101,"eps":0,"marketStatus":"Pre-Mkt","change":-0.05,"latestTime":"10-05 05:24:54 EDT","open":9.25,"high":9.2513,"low":9.035,"amount":4396944.699264,"amplitude":0.023639,"askPrice":8.98,"askSize":2469,"bidPrice":8.94,"bidSize":3075,"shortable":3,"etf":2,"ttmEps":0,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1791207000000},"marketStatusCode":1,"adr":0,"exchange":"ARCA","adjPreClose":9.1,"sharesOutstanding":4098101,"nav":9.16,"aum":35523405.16,"bidAskSpread":0,"preHourTrading":{"tag":"盘前","latestPrice":8.97,"preClose":9.1,"latestTime":"05:13 EDT","volume":1960,"amount":17442.32616,"timestamp":1791191590157,"change":-0.13,"changeRate":-0.014286,"amplitude":0.018791},"postHourTrading":{"tag":"盘后","latestPrice":9.06,"preClose":9.1,"latestTime":"19:59 EDT","volume":12629,"amount":114674.2047,"timestamp":1790985578973,"change":-0.04,"changeRate":-0.004396,"amplitude":0.010989},"volumeRatio":0.9371032241866823,"impliedVol":0.6586,"impliedVolPercentile":0.1968},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NVOX\",,,,,undefined,":{"symbol":"NVOX","floatShares":4188101,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.9371032241866823,"shares":4188101,"dividePrice":0,"high":9.2513,"amplitude":0.023639,"preClose":9.15,"low":9.035,"week52Low":9.035,"pbRate":"--","week52High":33.84,"institutionHeld":0,"latestPrice":9.1,"committee":0.109307,"eps":0,"divideRate":0,"volume":481216,"delay":0,"ttmEps":0,"open":9.25,"prevYearClose":21.89,"prevWeekClose":9.1,"prevMonthClose":9.41,"prevQuarterClose":9.41,"fiveDayClose":9.87,"twentyDayClose":15.19,"sixtyDayClose":16.595},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/NVOX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-12-09","symbol":"NVOX","defaultRemindTime":1765290600000,"type":"split","dateTimestamp":1765256400000,"forFactor":8,"toFactor":1,"ratio":8}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"NVOX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"NVOX\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"NVOX\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2671270754","title":"Patients Switching to Novo Nordisk's Wegovy Pill from Shots Lose More Weight in Real-World Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2671270754","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671270754?lang=en_us&edition=fundamental","pubTime":"2026-09-30 17:45","pubTimestamp":1790761500,"startTime":"0","endTime":"0","summary":"Patients switching toNovo Nordisk's Wegovy pill from shots lose more weight in real-world studySept 30 -Patients who switched from weight-loss injections to Novo Nordisk'sNOVOb.COdaily Wegovy pill continued to lose weight, according to data unveiled at a medical meeting on Wednesday, as the Danish drugmaker seeks to defend its lead over US rival Eli LillyLLY.Nin the market for oral obesity treatments.Study participants lost an average of 4.1% of their body weight over three months after transitioning from injectable obesity therapies — including Wegovy and Lilly's Zepbound — to oral semaglutide, the active ingredient in Wegovy, as well as Ozempic.Patients lost an average of 4.0 kg  from a baseline weight of 221.6 pounds  after making the switch, and the proportion of participants classified as clinically obese dropped to 65.5% from 87.1% after three months, with nearly 41% shedding at least 5% of their body weight.\"There's been a lot of questions on can people be compliant to the pill?","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260930:nL6N45L0IH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","IE00BZ1G4Q59.USD","LU1093756168.USD","NVO","LU0154236417.USD","NVOX","BK4585","PPH","OZEM","BK4007","LU1093756325.SGD","THNR","NVOH","BK4532","BK4599","IE00BKVL7J92.USD","NVOC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1176833437","title":"2026 Nobel Prize Preview: Scientists Behind GLP-1 Weight-Loss Drugs Emerge as Leading Contenders","url":"https://stock-news.laohu8.com/highlight/detail?id=1176833437","media":"Deep News","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1176833437?lang=en_us&edition=fundamental","pubTime":"2026-09-30 16:00","pubTimestamp":1790755226,"startTime":"0","endTime":"0","summary":"The 2026 Nobel Prize laureates will be announced successively from October 5 to 12. In order to understand the list of hot candidates, The Scientist published scientists' predictions for the 2026...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FHLC","PINK","RSPH","NVOX","ELIS","NVOC","NVOH","PJP","ELIL","MEDI","OZEM","JDOC","NBDS","XLVI","LLYX","FXH","CURE","TRUH","IYH","LLII","THNR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671321075","title":"Novo Says Ozempic Cuts Risk of Major Cardiovascular Events","url":"https://stock-news.laohu8.com/highlight/detail?id=2671321075","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671321075?lang=en_us&edition=fundamental","pubTime":"2026-09-29 22:13","pubTimestamp":1790691203,"startTime":"0","endTime":"0","summary":"BRIEF-Novo Says Ozempic Cuts Risk Of Major Cardiovascular EventsSept 29 (Reuters)-Novo Nordisk A/SNOVOb.CO:NOVO'S OZEMPIC (SEMAGLUTIDE) 2 MG ASSOCIATED WITH LOWER RISK OF MAJOR ADVERSE CARDIOVASCULAR ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260929:nFWN45K15E:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NVO","LU1093756168.USD","THNR","IE00BZ1G4Q59.USD","NVOX","NVOH","BK4588","BK4585","LU1093756325.SGD","PPH","BK4007","OZEM","LU0154236417.USD","BK4532","NVOC","BK4599","IE00BKVL7J92.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671210199","title":"Analysts Offer Insights on Healthcare Companies: Novo Nordisk (NVO), ClearPoint Neuro (CLPT) and Axsome Therapeutics (AXSM)","url":"https://stock-news.laohu8.com/highlight/detail?id=2671210199","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671210199?lang=en_us&edition=fundamental","pubTime":"2026-09-29 21:40","pubTimestamp":1790689233,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Novo Nordisk (NVO), ClearPoint Neuro (CLPT) and Ax...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-novo-nordisk-nvo-clearpoint-neuro-clpt-and-axsome-therapeutics-axsm-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-novo-nordisk-nvo-clearpoint-neuro-clpt-and-axsome-therapeutics-axsm-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2324357040.USD","BK4532","AXSM","NVOH","BK4599","THNR","PPH","IE00BKVL7J92.USD","BK4007","CLPT","LU1093756325.SGD","IE00BZ1G4Q59.USD","OZEM","LU0154236417.USD","NVOC","BK4585","BK4082","BK4588","LU1093756168.USD","BK4505","NVOX","NVO","PTH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671211626","title":"Eli Lilly Reports Zepbound Showed 4.5% Greater Weight Loss Than Novo Nordisk's Wegovy HD","url":"https://stock-news.laohu8.com/highlight/detail?id=2671211626","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671211626?lang=en_us&edition=fundamental","pubTime":"2026-09-29 20:02","pubTimestamp":1790683358,"startTime":"0","endTime":"0","summary":"Eli Lilly  said Tuesday that a new indirect analysis showed its drug Zepbound produced 4.5% greater weight loss than Novo Nordisk's  Wegovy HD in adults with obesity.The analysis compared data from the SURMOUNT-1 and STEP UP trials, according to the company.Patients taking a 15-milligram dose of Zepbound achieved the 4.5% greater average weight reduction over 72 weeks, the company said.Participants receiving a 10-milligram dose of the medication lost 3.2% more of their body weight on average compared with those on Wegovy HD, it said.Those taking the highest Zepbound dose were more than three times as likely to achieve at least a 20% reduction in body weight, and discontinuation rates due to adverse events were comparable across both treatments, Eli Lilly said.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0640476718.USD","LU0316494557.USD","IE00BJJMRY28.SGD","LU2023250504.SGD","LU2750360997.AUD","VHT","LU1712237335.SGD","LU2462157665.USD","LU1983299246.USD","IE00BN29S564.USD","LU0158827948.USD","LU0109391861.USD","LU0174119429.USD","LU0889565916.HKD","IE00B1XK9C88.USD","PJP","LU1366192091.USD","LU0345770308.USD","CANC","LU1127390331.HKD","LU1145028129.USD","LU2361044865.SGD","LU2896262040.SGD","LU2471134952.CNY","LU2491050071.SGD","SG9999001176.USD","LU0354030438.USD","LU0432979614.USD","LU1804176565.USD","NVOX","SGXZ31699556.SGD","LU0823434740.USD","LLY","LU1551013425.SGD","LU2168564495.EUR","LU2063271972.USD","LU2357305700.SGD","LU0683600562.USD","LU0786609619.USD","LU1069344957.HKD","LU1691799644.USD","LU1323610961.USD","IHE","NVO","LU2264538146.SGD","LU2361044949.HKD","LU0823416689.USD","NVOH","LU0256863902.USD","IE00BJT1NW94.SGD","IE00BKDWB100.SGD","IXJ","LU0353189680.USD","TRUH","IYH","THNR","LU2552382215.SGD","IE00B2B36J28.USD","LU1629891620.HKD","BK4533","LU0353189763.USD","LU0882574139.USD","LU2028103732.USD","LU2168564149.EUR","LU1023059063.AUD","LU0225283273.USD","LU0466842654.USD","IE00B4JS1V06.HKD","LU1868836591.USD","SGXZ51526630.SGD","LU1868836914.USD","BK4532","LU0471298777.SGD","LU2468319806.SGD","SG9999014880.SGD","SG9999018857.SGD","LU0058720904.USD","LU2237443622.USD","LU0943347566.SGD","MEDI","SGXZ99366536.SGD","LU0823434583.USD","IE00BWXC8680.SGD","IE00BFSS7M15.SGD","LU0234572021.USD","IE0001KFT4U8.USD","LU0106261372.USD","LU1720051108.HKD","LU2023251221.USD","LU2112291526.USD","LU0079474960.USD","LU0154236417.USD","IE00B775H168.HKD","SG9999017495.SGD","LU1093756325.SGD","LU1280957306.USD","LU2324357040.USD","LU2746668974.SGD","BK4534","LU2461242641.AUD","LU1064131342.USD","LU2237438978.USD","LU2236285917.USD","LU0094547139.USD","PPH","LU1868837300.USD","OZEM","LU1232071149.USD","IE00BZ1G4Q59.USD","LU0456855351.SGD","SG9999013999.USD","LU0096364046.USD","LU0820561818.USD","SG9999014906.USD","BK4599","LU0109394709.USD","LU0417517546.SGD","LU2552382058.USD","LU0203202063.USD","LU0964807845.USD","LU1061106388.HKD","LU1551013342.USD","LU2746668461.USD","LU2089984988.USD","LU0471298694.HKD","SG9999001176.SGD","LU1035775433.USD","XLV","LU2237443465.HKD","LU2237443549.SGD","SG9999015986.USD","SG9999014898.SGD","AGNG","LU0238689110.USD","LU1623119135.USD","IE00BJJMRX11.SGD","IE0004445239.USD","LU0385154629.USD","BK4581","HRTS","IE00BFTCPJ56.SGD","LU2168564065.EUR","LU2360106947.USD","LU2265009873.SGD","LU2271345857.HKD","LU2602419157.SGD","GB00BDT5M118.USD","LU2552382132.HKD","SGXZ57979304.SGD","SGXZ81514606.USD","LU2237443382.USD","LU0256863811.USD","LU2237443895.HKD","LU2491050154.USD","BK4516","LU2456880835.USD","LU1057294990.SGD","LU0689472784.USD","IE00BK4W5L77.USD","GDOC","LU1868837136.USD","MEDX","LU1267930730.SGD","LLYX","LU1979441026.SGD","IE0002141913.USD","LU2023250330.USD","LU0006306889.USD","LU2108987350.USD","IE00BJJMRZ35.SGD","LU2213496289.HKD","LU2491049909.HKD","JDOC","LU0354030511.USD","LU0672654240.SGD","LU2471134796.USD","RXL","LU1988902786.USD","SG9999015945.SGD","LU1720051017.SGD","BK4585","LU0820562030.AUD","LU0266013472.USD","LU2168563687.JPY","LU2361045086.USD","SG9999015978.USD","LU1989771016.USD","LU0097036916.USD","FTXH","LU0122379950.USD","LU0320765992.SGD","LU2471134879.HKD","TMED","LU0708995401.HKD","LLII","LU2087625088.SGD","LU0133085943.USD","IE0009355771.USD","LU1868836757.USD","SG9999018865.SGD","LU2089283258.USD","LU2417539215.USD","LU0320765059.SGD","WDNA","LU2756315664.SGD","MHIP","LU2462591350.SGD","LU0203201768.USD","FHLC","LU0882574055.USD","LU0289739699.SGD","LU1291159041.SGD","LU1917777945.USD","IE00BFSS8Q28.SGD","LU1814569148.SGD","IE0005OL40V9.USD","LU2089284900.SGD","LU2237443978.SGD","IE00B7KXQ091.USD","IE00BKPKM429.USD","LU0061475181.USD","LLYZ","LU0323591593.USD","IE00BKVL7J92.USD","LU1548497426.USD","ILDR","LU0198837287.USD","LU0820561909.HKD","LU2756315318.SGD","IE00B1BXHZ80.USD","LU2211815571.USD","SG9999014914.USD","ELIL","LU0787776722.HKD","BK4588","SG9999015952.SGD","LU0345770993.USD","CURE","IE0004445015.USD","LU2168564222.USD","LU2471134523.USD","IE00BK4W5M84.HKD","LU1093756168.USD","LU2106854487.HKD","NVOC","LU0114720955.EUR","IE00B4R5TH58.HKD","LU0158827781.USD","LU2111349929.HKD","BK4007","LU0210536198.USD","LU2750360641.GBP","ELIS","IE00BJLML261.HKD","LU1974910355.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671215761","title":"Lilly's Zepbound (Tirzepatide 10 Mg and 15 Mg) was Associated with More Weight Loss than Wegovy Hd (Semaglutide Injection 7.2 Mg) in a New Indirect Treatment Comparison","url":"https://stock-news.laohu8.com/highlight/detail?id=2671215761","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671215761?lang=en_us&edition=fundamental","pubTime":"2026-09-29 19:00","pubTimestamp":1790679602,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260929:nTUA7RLVWP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PJP","LU2491049909.HKD","LU2028103732.USD","LU0096364046.USD","LU0256863902.USD","LLY","SG9999018857.SGD","SGXZ51526630.SGD","GDOC","SG9999017495.SGD","BK4516","IYH","SGXZ81514606.USD","ELIS","LU1291159041.SGD","WDNA","LU0109394709.USD","LU0154236417.USD","LU2746668461.USD","IHE","LU1064131342.USD","LU0158827781.USD","LU0823434583.USD","MEDI","LU2471134879.HKD","LU0353189680.USD","IE0004445239.USD","LU2360106947.USD","LU2265009873.SGD","LU2471134523.USD","LU2552382132.HKD","LU2112291526.USD","LU2211815571.USD","IE00BFSS8Q28.SGD","LU0203201768.USD","SG9999013999.USD","LU0943347566.SGD","BK4599","LU1267930730.SGD","IE00B1BXHZ80.USD","FHLC","LU0097036916.USD","LU1093756168.USD","LU1868837300.USD","LU0316494557.USD","LU2361044949.HKD","LU2237443382.USD","LU1720051017.SGD","LU0210536198.USD","SG9999001176.SGD","LU2896262040.SGD","SG9999015945.SGD","LLYX","LU1061106388.HKD","LU0106261372.USD","LU0234572021.USD","LU2361045086.USD","IE00B775H168.HKD","LLII","LU1551013425.SGD","LU2106854487.HKD","LU2237443895.HKD","LU2023250504.SGD","LU1232071149.USD","CANC","IE0009355771.USD","LU1629891620.HKD","LU1868836757.USD","LU1917777945.USD","LU2237443465.HKD","SG9999001176.USD","OZEM","SG9999014914.USD","LU0683600562.USD","LU0345770308.USD","LU2471134796.USD","LU0094547139.USD","LU2236285917.USD","IE0005OL40V9.USD","LU2468319806.SGD","LU0471298777.SGD","NVOX","LU1814569148.SGD","LU0417517546.SGD","LU1983299246.USD","IE00B7KXQ091.USD","IE00BK4W5M84.HKD","IE00BZ1G4Q59.USD","IE0002141913.USD","LU1868836591.USD","SGXZ57979304.SGD","LU0823434740.USD","AGNG","IE00BN29S564.USD","THNR","BK4534","LU2023250330.USD","GB00BDT5M118.USD","LU0345770993.USD","LU0354030511.USD","LU2237438978.USD","LU2111349929.HKD","LU0708995401.HKD","LU2462591350.SGD","LU2361044865.SGD","LU1069344957.HKD","IE00BJT1NW94.SGD","LU2237443549.SGD","LU2237443978.SGD","LU2324357040.USD","LU2491050154.USD","VHT","LLYZ","LU0203202063.USD","LU0466842654.USD","IE00B1XK9C88.USD","IE00BJJMRY28.SGD","LU1989771016.USD","LU1280957306.USD","LU0122379950.USD","LU1988902786.USD","SG9999018865.SGD","LU0225283273.USD","IE00B4R5TH58.HKD","LU0323591593.USD","LU0289739699.SGD","LU1623119135.USD","IE00BJJMRX11.SGD","LU2087625088.SGD","LU2108987350.USD","NVO","NVOC","SGXZ31699556.SGD","SGXZ99366536.SGD","TMED","LU0174119429.USD","NVOH","LU0320765059.SGD","LU0354030438.USD","HRTS","LU1366192091.USD","LU1145028129.USD","LU0889565916.HKD","SG9999014906.USD","LU1551013342.USD","LU2168564065.EUR","LU2213496289.HKD","LU0456855351.SGD","IE00B2B36J28.USD","LU2552382215.SGD","BK4532","LU2461242641.AUD","LU1057294990.SGD","IE0004445015.USD","FTXH","LU0882574139.USD","TRUH","LU0256863811.USD","MEDX","LU2491050071.SGD","LU0823416689.USD","CURE","LU0640476718.USD","LU0198837287.USD","LU2750360641.GBP","XLV","IE00BJJMRZ35.SGD","LU0432979614.USD","LU2462157665.USD","IXJ","IE00BKDWB100.SGD","LU1323610961.USD","IE00B4JS1V06.HKD","LU2089284900.SGD","SG9999015978.USD","IE00BFSS7M15.SGD","IE00BKVL7J92.USD","LU0158827948.USD","JDOC","LU1974910355.USD","LU0820561909.HKD","LU0006306889.USD","LU0079474960.USD","MHIP","LU0320765992.SGD","RXL","SG9999015952.SGD","LU2471134952.CNY","LU0109391861.USD","SG9999014898.SGD","LU1548497426.USD","LU1720051108.HKD","LU2357305700.SGD","LU2063271972.USD","LU0689472784.USD","LU0353189763.USD","LU1804176565.USD","LU1979441026.SGD","LU2168564222.USD","LU2552382058.USD","IE00BK4W5L77.USD","LU2168564495.EUR","LU2756315318.SGD","LU0786609619.USD","LU0471298694.HKD","LU0964807845.USD","LU0882574055.USD","LU0114720955.EUR","LU2089984988.USD","LU2756315664.SGD","LU0672654240.SGD","SG9999014880.SGD","LU1127390331.HKD","LU2168563687.JPY","LU1712237335.SGD","LU1691799644.USD","LU2264538146.SGD","LU0266013472.USD","BK4581","LU0061475181.USD","LU2237443622.USD","LU2750360997.AUD","PPH","BK4007","IE00BKPKM429.USD","LU2023251221.USD","LU2417539215.USD","IE00BFTCPJ56.SGD","ELIL","LU0820561818.USD","LU2089283258.USD","LU1093756325.SGD","BK4533","IE00BWXC8680.SGD","LU1023059063.AUD","LU1035775433.USD","LU1868836914.USD","SG9999015986.USD","LU2271345857.HKD","LU2746668974.SGD","LU0385154629.USD","ILDR","LU0058720904.USD","LU0820562030.AUD","LU0133085943.USD","LU0238689110.USD","IE0001KFT4U8.USD","IE00BJLML261.HKD","LU1868837136.USD","LU2168564149.EUR","BK4588","LU2602419157.SGD","LU2456880835.USD","BK4585","LU0787776722.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671132642","title":"Novo Nordisk Says Ozempic Shows Lower Risk of Cardiovascular Events Compared to Eli Lilly's Mounjaro","url":"https://stock-news.laohu8.com/highlight/detail?id=2671132642","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671132642?lang=en_us&edition=fundamental","pubTime":"2026-09-29 18:28","pubTimestamp":1790677698,"startTime":"0","endTime":"0","summary":"Novo Nordisk says Ozempic shows lower risk of cardiovascular events compared to Eli Lilly's MounjaroCOPENHAGEN, Sept 29 (Reuters)-Novo NordiskNOVOb.COsaid on Tuesday a real-world study found that adul","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260929:nL8N45L0SH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0640476718.USD","LU0316494557.USD","IE00BJJMRY28.SGD","LU2023250504.SGD","LU2750360997.AUD","VHT","LU1712237335.SGD","LU2462157665.USD","LU1983299246.USD","IE00BN29S564.USD","LU0158827948.USD","LU0109391861.USD","LU0174119429.USD","LU0889565916.HKD","IE00B1XK9C88.USD","PJP","LU1366192091.USD","LU0345770308.USD","CANC","LU1127390331.HKD","LU1145028129.USD","LU2361044865.SGD","LU2896262040.SGD","LU2471134952.CNY","LU2491050071.SGD","SG9999001176.USD","LU0354030438.USD","LU0432979614.USD","LU1804176565.USD","NVOX","SGXZ31699556.SGD","LU0823434740.USD","LLY","LU1551013425.SGD","LU2168564495.EUR","LU2063271972.USD","LU2357305700.SGD","LU0683600562.USD","LU0786609619.USD","LU1069344957.HKD","LU1691799644.USD","LU1323610961.USD","IHE","NVO","LU2264538146.SGD","LU2361044949.HKD","LU0823416689.USD","NVOH","LU0256863902.USD","IE00BJT1NW94.SGD","IE00BKDWB100.SGD","IXJ","LU0353189680.USD","TRUH","IYH","THNR","LU2552382215.SGD","IE00B2B36J28.USD","LU1629891620.HKD","BK4533","LU0353189763.USD","LU0882574139.USD","LU2028103732.USD","LU2168564149.EUR","LU1023059063.AUD","LU0225283273.USD","LU0466842654.USD","IE00B4JS1V06.HKD","LU1868836591.USD","SGXZ51526630.SGD","LU1868836914.USD","BK4532","LU0471298777.SGD","LU2468319806.SGD","SG9999014880.SGD","SG9999018857.SGD","LU0058720904.USD","LU2237443622.USD","LU0943347566.SGD","MEDI","SGXZ99366536.SGD","LU0823434583.USD","IE00BWXC8680.SGD","IE00BFSS7M15.SGD","LU0234572021.USD","IE0001KFT4U8.USD","LU0106261372.USD","LU1720051108.HKD","LU2023251221.USD","LU2112291526.USD","LU0079474960.USD","LU0154236417.USD","IE00B775H168.HKD","SG9999017495.SGD","LU1093756325.SGD","LU1280957306.USD","LU2324357040.USD","LU2746668974.SGD","BK4534","LU2461242641.AUD","LU1064131342.USD","LU2237438978.USD","LU2236285917.USD","LU0094547139.USD","PPH","LU1868837300.USD","OZEM","LU1232071149.USD","IE00BZ1G4Q59.USD","LU0456855351.SGD","SG9999013999.USD","LU0096364046.USD","LU0820561818.USD","SG9999014906.USD","BK4599","LU0109394709.USD","LU0417517546.SGD","LU2552382058.USD","LU0203202063.USD","LU0964807845.USD","LU1061106388.HKD","LU1551013342.USD","LU2746668461.USD","LU2089984988.USD","LU0471298694.HKD","SG9999001176.SGD","LU1035775433.USD","XLV","LU2237443465.HKD","LU2237443549.SGD","SG9999015986.USD","SG9999014898.SGD","AGNG","LU0238689110.USD","LU1623119135.USD","IE00BJJMRX11.SGD","IE0004445239.USD","LU0385154629.USD","BK4581","HRTS","IE00BFTCPJ56.SGD","LU2168564065.EUR","LU2360106947.USD","LU2265009873.SGD","LU2271345857.HKD","LU2602419157.SGD","GB00BDT5M118.USD","LU2552382132.HKD","SGXZ57979304.SGD","SGXZ81514606.USD","LU2237443382.USD","LU0256863811.USD","LU2237443895.HKD","LU2491050154.USD","BK4516","LU2456880835.USD","LU1057294990.SGD","LU0689472784.USD","IE00BK4W5L77.USD","GDOC","LU1868837136.USD","MEDX","LU1267930730.SGD","LLYX","LU1979441026.SGD","IE0002141913.USD","LU2023250330.USD","LU0006306889.USD","LU2108987350.USD","IE00BJJMRZ35.SGD","LU2213496289.HKD","LU2491049909.HKD","JDOC","LU0354030511.USD","LU0672654240.SGD","LU2471134796.USD","RXL","LU1988902786.USD","SG9999015945.SGD","LU1720051017.SGD","BK4585","LU0820562030.AUD","LU0266013472.USD","LU2168563687.JPY","LU2361045086.USD","SG9999015978.USD","LU1989771016.USD","LU0097036916.USD","FTXH","LU0122379950.USD","LU0320765992.SGD","LU2471134879.HKD","TMED","LU0708995401.HKD","LLII","LU2087625088.SGD","LU0133085943.USD","IE0009355771.USD","LU1868836757.USD","SG9999018865.SGD","LU2089283258.USD","LU2417539215.USD","LU0320765059.SGD","WDNA","LU2756315664.SGD","MHIP","LU2462591350.SGD","LU0203201768.USD","FHLC","LU0882574055.USD","LU0289739699.SGD","LU1291159041.SGD","LU1917777945.USD","IE00BFSS8Q28.SGD","LU1814569148.SGD","IE0005OL40V9.USD","LU2089284900.SGD","LU2237443978.SGD","IE00B7KXQ091.USD","IE00BKPKM429.USD","LU0061475181.USD","LLYZ","LU0323591593.USD","IE00BKVL7J92.USD","LU1548497426.USD","ILDR","LU0198837287.USD","LU0820561909.HKD","LU2756315318.SGD","IE00B1BXHZ80.USD","LU2211815571.USD","SG9999014914.USD","ELIL","LU0787776722.HKD","BK4588","SG9999015952.SGD","LU0345770993.USD","CURE","IE0004445015.USD","LU2168564222.USD","LU2471134523.USD","IE00BK4W5M84.HKD","LU1093756168.USD","LU2106854487.HKD","NVOC","LU0114720955.EUR","IE00B4R5TH58.HKD","LU0158827781.USD","LU2111349929.HKD","BK4007","LU0210536198.USD","LU2750360641.GBP","ELIS","IE00BJLML261.HKD","LU1974910355.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671134942","title":"Novo Nordisk announces retrospective RWE on Ozempic in type 2 diabets","url":"https://stock-news.laohu8.com/highlight/detail?id=2671134942","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671134942?lang=en_us&edition=fundamental","pubTime":"2026-09-29 18:10","pubTimestamp":1790676619,"startTime":"0","endTime":"0","summary":"Novo Nordisk (NVO) announced new retrospective real-world evidence in adults with type 2 diabetes treated with once-weekly semaglutide injection 1 ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/novo-nordisk-announces-retrospective-rwe-on-ozempic-in-type-2-diabets-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/novo-nordisk-announces-retrospective-rwe-on-ozempic-in-type-2-diabets-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4599","BK4007","BK4588","BK4585","LU0154236417.USD","BK4532","THNR","IE00BZ1G4Q59.USD","PPH","OZEM","NVOX","LU1093756168.USD","LU1093756325.SGD","NVOH","IE00BKVL7J92.USD","NVOC","NVO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671218563","title":"Novo Nordisk Strikes Second Licensing Deal Since Frosty Capital-Markets Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2671218563","media":"Dow Jones","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671218563?lang=en_us&edition=fundamental","pubTime":"2026-09-29 17:46","pubTimestamp":1790675160,"startTime":"0","endTime":"0","summary":"Danish drugmaker to pay up to $2.6 billion for Chinese obesity pill candidateNovo Nordisk struck a licensing deal.Novo Nordisk on Tuesday struck its second licensing deal since receiving a poor recept","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1093756168.USD","IE00BKVL7J92.USD","BK4599","LU0359201612.USD","BK4532","NVOH","LU0154236417.USD","LU0359201885.HKD","NVOC","BK4007","BK1191","LU0359202008.SGD","THNR","NVOX","01276","LU2543165471.USD","BK4588","LU1023057109.AUD","BK4585","IE00BZ1G4Q59.USD","600276","OZEM","PPH","LU1093756325.SGD","NVO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671298568","title":"China's Hengrui Inks up to $2.6 Billion Deal with Novo Nordisk for Obesity Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2671298568","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671298568?lang=en_us&edition=fundamental","pubTime":"2026-09-29 13:10","pubTimestamp":1790658607,"startTime":"0","endTime":"0","summary":"Sept 29 (Reuters) - Jiangsu $Hengrui Pharmaceuticals(01276)$, China's largest drugmaker by ‌market value, said on Tuesday it will license global rights to ⁠its weight-management drug HRS-1596 to...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260929:nL4N45L0BV:1","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":"China's Hengrui Inks up to $2.6 Billion Deal with Novo Nordisk for Obesity Drug","news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0183","LU2580892789.USD","LU0405327148.USD","LU1969619763.USD","NVOX","600276","LU1781817850.SGD","BK0028","LU2097828474.EUR","LU1820825898.SGD","BK0188","LU1997245177.USD","LU0405327494.USD","LU1655091616.SGD","LU2097828557.USD","LU2580892862.HKD","BK0012","NVOC","LU2097828631.EUR","LU2488822045.USD","BK0060","LU1255011170.USD","BK0239","LU2328871848.SGD","NVOH","LU2148510915.USD","BK0196","LU1997244956.HKD","LU1064131003.USD","LU1328615791.USD","LU1997245094.SGD","LU2289578879.USD","NVO","LU1064130708.USD","LU2097828805.USD","LU1146622755.USD","01276","LU2495084118.USD","LU1580142542.USD","LU2097828714.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1107831327","title":"Hengrui Pharma and Novo Nordisk Sign Licensing Agreement for HRS-1596 Project","url":"https://stock-news.laohu8.com/highlight/detail?id=1107831327","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1107831327?lang=en_us&edition=fundamental","pubTime":"2026-09-29 12:49","pubTimestamp":1790657347,"startTime":"0","endTime":"0","summary":"Hengrui Pharma (600276.SH) announced that the company has entered into an agreement with Novo Nordisk A/S to license its potential once-weekly oral GLP-1 and GIP dual receptor agonist HRS-1596 to...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BKVL7J92.USD","BK0196","NVOC","LU2097828557.USD","LU2328871848.SGD","BK0060","BK4532","LU2495084118.USD","NVOH","LU2097828805.USD","LU2488822045.USD","LU2580892862.HKD","LU1255011170.USD","THNR","LU1064131003.USD","LU1969619763.USD","LU1997245094.SGD","LU2097828714.EUR","BK4007","BK4588","LU1997245177.USD","LU1093756325.SGD","NVOX","LU0405327494.USD","LU1820825898.SGD","LU2580892789.USD","LU1655091616.SGD","LU1328615791.USD","BK0012","LU0405327148.USD","LU2148510915.USD","01276","LU1093756168.USD","BK4599","LU0154236417.USD","600276","LU1580142542.USD","LU1781817850.SGD","BK0239","LU2097828631.EUR","IE00BZ1G4Q59.USD","BK4585","NVO","LU1064130708.USD","PPH","LU2097828474.EUR","BK0183","OZEM","LU1997244956.HKD","LU1146622755.USD","LU2289578879.USD","BK0188","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671250134","title":"Option traders moderately bearish in Novo Nordisk with shares down 0.22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2671250134","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671250134?lang=en_us&edition=fundamental","pubTime":"2026-09-29 04:30","pubTimestamp":1790627411,"startTime":"0","endTime":"0","summary":"Option traders moderately bearish in Novo Nordisk (NVO), with shares down 8c near $38.72. Options volume roughly in line with average with 78k cont...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/option-traders-moderately-bearish-in-novo-nordisk-with-shares-down-0-22-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/option-traders-moderately-bearish-in-novo-nordisk-with-shares-down-0-22-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","NVOH","BK4532","NVOC","PPH","BK4585","NVO","BK4599","OZEM","LU0154236417.USD","NVOX","IE00BKVL7J92.USD","THNR","BK4007","LU1093756325.SGD","IE00BZ1G4Q59.USD","LU1093756168.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671999259","title":"Novo Nordisk A/S Series B Stock Falls Monday, Outperforms Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2671999259","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671999259?lang=en_us&edition=fundamental","pubTime":"2026-09-29 00:03","pubTimestamp":1790611380,"startTime":"0","endTime":"0","summary":"This article was automatically generated using Dow Jones technology.Shares of Novo Nordisk A/S Series B dropped 0.3% to DKK252.25 Monday on what proved to be an overall unfavorable trading session for the stock market, with the OMX Nordic 40 Index falling 0.6% to 2,608.33.The company closed DKK157.70 short of its 52-week high of DKK409.95, which the company achieved on January 23, 2026.Trading volume was 4,679,253, compared to the 50-day average trading volume of 4,699,277.Data source: Dow Jones Market Data, FactSet","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BKVL7J92.USD","NVOH","IE00BZ1G4Q59.USD","LU0154236417.USD","NVO","THNR","LU1093756325.SGD","BK4007","BK4532","LU1093756168.USD","OZEM","BK4585","PPH","NVOC","BK4599","NVOX","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670452237","title":"Taking Ozempic? a Routine Eye Exam Could Help You Understand Your Risk for Vision Loss","url":"https://stock-news.laohu8.com/highlight/detail?id=2670452237","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670452237?lang=en_us&edition=fundamental","pubTime":"2026-09-28 20:42","pubTimestamp":1790599320,"startTime":"0","endTime":"0","summary":"Some research suggests that GLP-1 medications may elevate the risk of a rare form of vision loss, though that link has not been proven in a rigorous studySeveral studies have suggested that Ozempic an","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0210536198.USD","LU2462591350.SGD","LU2211815571.USD","IE00BJLML261.HKD","LU0432979614.USD","SGXZ31699556.SGD","IE0004445015.USD","IE00BJJMRX11.SGD","LU0943347566.SGD","LU1814569148.SGD","LU2023250504.SGD","SG9999001176.USD","IE00B1XK9C88.USD","LU2023251221.USD","LU0320765059.SGD","LU2264538146.SGD","LU0787776722.HKD","SG9999014880.SGD","LU2237443382.USD","LLII","LU2602419157.SGD","LU2237443549.SGD","IE00BKDWB100.SGD","IE0002141913.USD","LU2168563687.JPY","LU1551013342.USD","LU2089984988.USD","LU2236285917.USD","SGXZ51526630.SGD","LU1989771016.USD","LU2552382132.HKD","MHIP","LU1623119135.USD","LU0316494557.USD","FTXH","LU0323591593.USD","LU1868836591.USD","SGXZ99366536.SGD","BK4534","LU2265009873.SGD","BK4599","LU0256863902.USD","LU2491050071.SGD","LU1868837300.USD","LU2237443465.HKD","BK4588","LU2461242641.AUD","LU0823434740.USD","LLYZ","SG9999018865.SGD","LU1069344957.HKD","LU1720051017.SGD","LU1232071149.USD","TRUH","CURE","IYH","LU1366192091.USD","SG9999017495.SGD","LU0174119429.USD","BK4585","MEDX","LU1983299246.USD","SG9999013999.USD","LU2089284900.SGD","LU0096364046.USD","ELIS","LU2108987350.USD","IE00BFSS7M15.SGD","LU2237438978.USD","LU2271345857.HKD","LU0234572021.USD","LU2357305700.SGD","OZEM","LU0154236417.USD","LU2361044865.SGD","LU0672654240.SGD","LU0823434583.USD","LU0058720904.USD","LU2168564065.EUR","LU1093756168.USD","IE00B4R5TH58.HKD","LU1551013425.SGD","IE00BJJMRY28.SGD","LU1917777945.USD","LU2456880835.USD","LU1093756325.SGD","LU2746668461.USD","LU2750360641.GBP","LU2237443978.SGD","PPH","SG9999015986.USD","BK4581","BK4516","IE00B1BXHZ80.USD","IE00BJT1NW94.SGD","BK4533","LU0385154629.USD","NVOC","LU0114720955.EUR","LU1974910355.USD","LU1629891620.HKD","IE00BFTCPJ56.SGD","LU1720051108.HKD","LU0203201768.USD","LU0353189680.USD","LU1691799644.USD","LU2106854487.HKD","IE0009355771.USD","LU0158827781.USD","LU1064131342.USD","LU2168564495.EUR","LU1868836757.USD","LU0109391861.USD","LU0238689110.USD","LU0882574055.USD","VHT","IE00BFSS8Q28.SGD","SG9999014898.SGD","IHE","IE00BN29S564.USD","LU0823416689.USD","LU2491049909.HKD","LU0456855351.SGD","LU2063271972.USD","LU0354030438.USD","LU2750360997.AUD","IE00BK4W5M84.HKD","LU2471134523.USD","LU1057294990.SGD","ELIL","LU2756315664.SGD","LU1979441026.SGD","FHLC","SG9999015978.USD","LU2361045086.USD","LU0820562030.AUD","LU0640476718.USD","LU2023250330.USD","LU2896262040.SGD","LU1267930730.SGD","LU2361044949.HKD","LU2324357040.USD","SG9999014906.USD","LU1291159041.SGD","BK4532","LU0689472784.USD","LU0158827948.USD","LU2087625088.SGD","LU0198837287.USD","LU0256863811.USD","LU2471134879.HKD","MEDI","NVOH","LU1127390331.HKD","LU2168564149.EUR","LU0079474960.USD","LU0708995401.HKD","LU1868836914.USD","LU0882574139.USD","LU1023059063.AUD","SG9999001176.SGD","LU2112291526.USD","LU0097036916.USD","LU0006306889.USD","NVO","SG9999014914.USD","LU2471134796.USD","LU0683600562.USD","LU0094547139.USD","SG9999018857.SGD","LU0820561909.HKD","WDNA","LU0061475181.USD","LU2360106947.USD","IE00B7KXQ091.USD","LU0345770308.USD","SGXZ57979304.SGD","XLV","LU1280957306.USD","GDOC","LU0225283273.USD","LU0471298777.SGD","LU2491050154.USD","LU0266013472.USD","LU0786609619.USD","IE00B2B36J28.USD","LU2111349929.HKD","GB00BDT5M118.USD","LU2471134952.CNY","LU2746668974.SGD","LU1145028129.USD","LU2237443622.USD","IE00BZ1G4Q59.USD","IXJ","LU1988902786.USD","LU1868837136.USD","LU0889565916.HKD","LU2552382058.USD","LU2756315318.SGD","TMED","LU0106261372.USD","LU1712237335.SGD","SG9999015945.SGD","CANC","LU1548497426.USD","LU1323610961.USD","IE00BKPKM429.USD","SG9999015952.SGD","IE0001KFT4U8.USD","LU0320765992.SGD","LU0109394709.USD","LU2028103732.USD","LU2168564222.USD","RXL","IE00BKVL7J92.USD","LU0353189763.USD","LU2468319806.SGD","LU2237443895.HKD","LU2213496289.HKD","LU0345770993.USD","BK4007","IE0004445239.USD","ILDR","LLYX","LU0122379950.USD","LU0417517546.SGD","LU1035775433.USD","THNR","SGXZ81514606.USD","LU0354030511.USD","IE00BK4W5L77.USD","LLY","LU0289739699.SGD","IE00B4JS1V06.HKD","LU0820561818.USD","LU2552382215.SGD","LU0133085943.USD","PJP","IE0005OL40V9.USD","LU1061106388.HKD","AGNG","HRTS","LU0466842654.USD","LU0203202063.USD","LU1804176565.USD","NVOX","LU2417539215.USD","IE00BWXC8680.SGD","LU0471298694.HKD","LU0964807845.USD","IE00B775H168.HKD","LU2089283258.USD","LU2462157665.USD","IE00BJJMRZ35.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1146858839","title":"ETF Weekly | QCML Soars 27%; INTW, AMUU, FBL, AMDL Jump 26%; SOXL Rallies 22%; Semiconductor Longs Lead","url":"https://stock-news.laohu8.com/highlight/detail?id=1146858839","media":"ETF Weekly","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1146858839?lang=en_us&edition=fundamental","pubTime":"2026-09-27 08:00","pubTimestamp":1790467200,"startTime":"0","endTime":"0","summary":"Market OverviewFor Sep 21 – Sep 25, 2026, the Dow Jones Industrial Average gained 0.28%, the S&P 500 rose 1.21%, and the Nasdaq Composite advanced 2.06%.ETF market tone was constructive, with...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"1b73ff2cc9bf460e9cf84e18c58740f6","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2347655156.SGD","LU1699723380.USD","LU0048584097.USD","LU0823434583.USD","BIL","PPH","NVOX","LU0823434740.USD","LU0354030511.USD","LU1267930490.SGD","ERX","KORU","IE00B1BXHZ80.USD","BK4581","SG9999014880.SGD","IE00BQXX3D17.EUR","LU0661504455.SGD","LU0203202063.USD","LU1506573853.SGD","SG9999004303.SGD","LU0353189763.USD","GLL","LU0109392836.USD","LU0964807845.USD","LU1861220033.SGD","IE000ITXATA3.USD","IE00B775H168.HKD","BK4573","LU0784385170.HKD","LU1839511570.USD","LU2552382215.SGD","LU2404859667.USD","IE00BKDWB100.SGD","BK4588","LU0859254822.USD","LU2357627491.SGD","SGXZ31699556.SGD","AMDS","WUGI","LU0210536198.USD","LU2106854487.HKD","GAMR","BK4007","LU0211331839.USD","LU1435385759.SGD","SPXU","METU","LU0203201768.USD","LU1778281490.HKD","LU1429558221.USD","LU0170899867.USD","IE00BGHQDM52.EUR","LU0320765059.SGD","LU1564329032.USD","LU1923623000.USD","LU1934455277.USD","LU1153585028.USD","LU1868837136.USD","THNR","LU0072461881.USD","GLD","LU1564329461.SGD","LU1069344957.HKD","QCMU","SG9999018857.SGD","SG9999002224.SGD","LU1868836591.USD","IE00BJTD4N35.SGD","IE0034235188.USD","DUST","BK4543","ZSL","IE00B3SWFQ91.USD","LU2417539215.USD","BK4507","LU1674673691.USD","SPYQ","IE00BWXC8680.SGD","LU0545039389.USD","LU0056508442.USD","BK7062","LU1691799644.USD","SG9999014914.USD","CHPS","BK4529","LU1914381329.SGD","XLC","FBX","LU1815336760.USD","BK7095","LU0234570918.USD","LU0912757837.SGD","LU2756315318.SGD","IE00BVYPNQ40.USD","ARTY","LU1116320737.USD","AMDW","LU0965509283.SGD","DBC","BK4602","AIQ","RSPC","LU0417517546.SGD","LU1720051017.SGD","IE00BKPKM429.USD","SG9999015952.SGD","HIBL","LU2746668974.SGD","BCDF","GXPC","LEGR","BK4534","IE00B5949003.HKD","LU0823421333.USD","NUGT","SG9999002232.USD","LU1261432733.SGD","LU2125154935.USD","ORCX","LU0174119429.USD","VOO","IETC","LU2764263039.SGD","SOXY","LU0157215616.USD","LU0552385451.USD","SG9999015945.SGD","CHAT","BK4515","IE00BJJMRY28.SGD","SMH","LU0251131958.USD","DYNI","BK4561","LU1823568750.SGD","LU1861558580.USD","LU1868836757.USD","BK4593","LU0882574139.USD","BK4524","LU0390134368.USD","LU1935042215.USD","LU0011850046.USD","LU2065170008.USD","LU1035775433.USD","SIVR","LU2347655073.USD","METW","LU0097036916.USD","LU0348723411.USD","GLDM","LU2168563687.JPY","IE0004445015.USD","LU1951198990.SGD","LU2602419157.SGD","LU0683600562.USD","LU0077335932.USD","LU2461242641.AUD","LU2430703178.SGD","LU1066053197.SGD","LU2210149790.SGD","IE0009G5SDU7.USD","AMDY","LU0528227936.USD","IE00BGHQF748.EUR","DBB","SG9999014021.USD","BGLD","ORAC","IE000YTNTUN2.SGD","DGZ","IGLD","LU0211327993.USD","QCMD","IAU","METD","IE00BJLML261.HKD","LU0079474960.USD","LU0444973449.USD","LU2361044865.SGD","IE000F7OJYX1.SGD","LU0726765562.USD","UGL","IE00BQXX3F31.USD","IE00BN8TJ469.HKD","SGXZ51526630.SGD","LU0690374961.EUR","LU0820561909.HKD","LU2430703095.HKD","LU0965509101.SGD","FWD","LU1564329115.USD","BKIV","IE00BN0W2T93.GBP","META","LU0354030438.USD","INTW","ERY","LU0096364046.USD","BK4592","LU1059921491.USD","LU2317271919.USD","QQQX","LU0820562030.AUD","LU1242518931.SGD","LU0466842654.USD","AIS","LU2065169927.USD","LU2168564222.USD","LU0792757196.USD","LU2237957902.USD","LU0162691827.USD","SPY","LU0316494557.USD","YGLD","LU0265550359.USD","LU1127390331.HKD","SOXX","BK7016","LU0215105999.USD","SG9999015986.USD","IE0005OL40V9.USD","CNAV","GDXW","FTXL","LU0345769128.USD","YSPY","IE0009356076.USD","METQ","OGIG","LU1852331112.SGD","LU0187121727.USD","IE00BQXX3C00.GBP","LU1935043023.USD","LU0788109477.HKD","LU1989764748.USD","IE00BLSP4452.SGD","DMAX","INT","LU2473716301.USD","SHNY","LU2404859741.USD","SG9999014039.USD","BK4141","LU0234572021.USD","LU1670627923.USD","LU0061474960.USD","CHPY","LU0868494617.USD","LU1069347547.HKD","LU1697837992.HKD","LU2065171311.SGD","LU0672654240.SGD","ICVT","BK4535","IE0003U64NQ7.SGD","LU0738911758.USD","LU0109391861.USD","BK4605","LU0149725797.USD","LU2168564149.EUR","LU0070217475.USD","LU2244417387.USD","LU1951200564.SGD","LU1303367103.USD","METG","LU2430703251.USD","LU2242649171.HKD","BK4599","LU1116320901.HKD","LU0256863902.USD","IE00BN0W2W23.USD","LU1551013425.SGD","LU2108987350.USD","SGXZ80539844.SGD","VDE","LU2462157665.USD","IE000WAW04H5.SGD","DAMD","LU0130102774.USD","LU0175139822.USD","SPYU","LU1235294995.USD","NVO","SMHX","LU0127658192.USD","IE00BKVL7J92.USD","LU1974910355.USD","FLOT.AU","EDC","LU0106261372.USD","LU2063271972.USD","LU2764262908.HKD","IE000BZT7R73.USD","LU0979878070.USD","LU1934455863.HKD","LU1935042991.SGD","IE000SO60NU8.SGD","TDIV","ORCZ","LU0203347892.USD","IE00BBT3K403.USD","LU0889566641.SGD","LU2272731600.USD","EWY","USXF","KOLD","SOXQ","AMDU","IE00B7KXQ091.USD","BK4585","LU2357305700.SGD","LU1267930730.SGD","LU0265550946.USD","LU0274383776.USD","IE00B19Z8W00.USD","SOCL","LTL","LU2264538146.SGD","IE00BMPRXN33.USD","LU1934455194.USD","ILDR","LU0957808578.USD","AMYY","AMUU","LU0868494708.USD","LU1803068979.SGD","LU1037948897.HKD","IE00BN29S564.USD","LU0053666078.USD","NVOH","OUNZ","LU1074936037.SGD","LU2420271590.USD","BK4538","LU1988902786.USD","LU2403377893.USD","LU0823421416.USD","AMDG","BK4077","IAUM","LU2360032135.SGD","LU0724617625.USD","LU0154236417.USD","LU0133085943.USD","LU1046421795.USD","SG9999015978.USD","LU1880398471.USD","NULC","IE00B775SV38.USD","BAR","LU2247934214.USD","IE00B3S45H60.SGD","LU0553294199.USD","BK4582","LU1066051225.USD","SG9999014898.SGD","BK4614","BK7142","CLCG","LU0965509010.AUD","LU0795875086.SGD","LU1489326972.SGD","LU0251142724.SGD","LU1629891620.HKD","BK7104","LU2265009873.SGD","LU0256863811.USD","LU1732799900.SGD","LU0082616367.USD","SSO","FBL","XDAT","BAI","INTC","LU0642271901.SGD","LU1267930813.SGD","LU2764263203.CNY","LU2361044949.HKD","MMAX","LINT","LU2125154778.USD","IE00B3QW5Z07.USD","IE00B19Z3B42.SGD","SGXZ99366536.SGD","AMDL","LU0985489474.SGD","IE00B64PRP62.GBP","LU2250418816.HKD","LU0640476718.USD","IE00BJJMRX11.SGD","LU2097829019.USD","QCML","QQQP","IE00BK4W5M84.HKD","LU0072462426.USD","SOXL","BK4604","USD","LU0267386448.USD","BK4612","BK4554","IE0034235303.USD","LU0276348264.USD","LU0048573561.USD","LU2756315664.SGD","IE000M9KFDE8.USD","IE00B19Z8X17.USD","FGDL","TEK","IE00BJTD4V19.USD","LCLG","LU1791710582.SGD","LU2098885051.SGD","HK0000304805.HKD","LU1791710400.SGD","LU2456880835.USD","LU2355687059.USD","LU1037948541.HKD","LU0787776722.HKD","TTEQ","LU1670711123.USD","LU0345769631.USD","LU2087625088.SGD","HK0000914660.USD","LU1989772840.SGD","LU0784383803.USD","LU1093756325.SGD","LU2896262040.SGD","INYY","IE00BFSS7M15.SGD","LU1935043536.SGD","HK0000304797.USD","IE00BVYPNP33.GBP","LU2462591350.SGD","UNG","LU1670628061.USD","BK4512","HK0000914686.HKD","LU1366192091.USD","LU2133065610.SGD","LU2210150020.SGD","SGXZ81514606.USD","SPUU","SMAX","LU1935042488.USD","LU1145028129.USD","IE00BFSS8Q28.SGD","LU0070302665.USD","LU2023250843.SGD","LU1861559042.SGD","LU2089985449.USD","IAUI","IE00BZ1G4Q59.USD","SGXZ23171101.USD","FAZ","LU0949170772.SGD","AMD","LU2326559502.SGD","SG9999014013.SGD","LU1551013342.USD","LU0943347566.SGD","LU0211328371.USD","LU0719512351.SGD","LU0784385840.USD","LU0068578508.USD","LU0006306889.USD","IE00B4JS1V06.HKD","FNGO","PSI","LU0689472784.USD","LU2322448957.HKD","BWET","QCOM","LU2592432038.USD","LU1244550221.USD","SLV","FCOM","ORCL","LU0321505868.SGD","LU2720916845.USD","SG9999011175.SGD","LU0096362180.USD","IE000W1ABFV2.USD","LU1280957306.USD","DGP","LU2236285917.USD","FDN","IE000MB6IJN5.SGD","LU0433182093.SGD","LU0648001328.SGD","LU2543165471.USD","SG9999003800.SGD","IE00B1XK9C88.USD","BK4097","IE00BK4W5L77.USD","LU2272731865.HKD","BK4516","LU0980610538.SGD","LU0795875169.SGD","LU0308772762.SGD","LU0289960550.SGD","QQQA","LU0208291251.USD","GB00B4QBRK32.GBP","LU0081259029.USD","LU0690374615.EUR","LU2360106780.USD","LU2360107168.USD","LU0957791311.USD","LU2458330169.SGD","BK4587","ORCU","LU0353189680.USD","LU0314106906.USD","METV","LU0314104364.USD","LU1316542783.SGD","LU0861579265.USD","DUG","LU1868837300.USD","LU0323591593.USD","LU0949170426.SGD","LU2746668461.USD","LU0210533765.USD","GUNR","LU1861215975.USD","SPDN","LU0080751232.USD","USG","BK4598","NVOC","LU1917777945.USD","SG9999017495.SGD","LU2237957811.SGD","SG9999014005.SGD","LU0786609619.USD","LU0965508806.USD","LU2361045086.USD","LU0061475181.USD","LU2148611432.USD","LU2487616109.SGD","IE00B19Z3581.USD","LU2087621335.USD","IE0000B7K699.USD","LU2458330243.SGD","LU0444971666.USD","LU1003077747.HKD","LU0251132253.USD","LU2065171402.SGD","LU1244550494.USD","SG9999014906.USD","SPYH","LU1066051811.HKD","SDS","TRUC","LU2242650005.HKD","LU1093756168.USD","AMDD","IE00BSNM7G36.USD","TECY","VGT","GB00B4LPDJ14.GBP","KGLD","VOX","WISE","BK4533","LU2168564065.EUR","LU1992135399.USD","LU2552382058.USD","LU0198837287.USD","TEKX","LU0889565833.HKD","BK4579","LU2505996681.GBP","LU2168564495.EUR","FCVT","LU1992135472.HKD","LU1571399168.USD","XNTK","BK4527","LU0210528500.USD","LU0708995401.HKD","LU0225283273.USD","LU1814569148.SGD","LU2505996509.AUD","FAI","ORCS","LU0742534661.SGD","LU1366333091.USD","LU2860962120.EUR","GB00BDT5M118.USD","OZEM","LU1732800096.USD","LU2213496289.HKD","SGOL","UPRO","LU0985320562.USD","IE00BN0W2V16.EUR","LU1119994496.HKD","SOXS","BK4550","LU1989764664.SGD","IE0002270589.USD","LU1670711040.USD","LU0942090050.USD","BK4112","SPXL","FBY","LU1301847155.USD","LU1720051108.HKD","AMDC","LU1880398554.USD","IE00BMPRXR70.SGD","IE00BMPRXQ63.HKD","LU1989772923.USD","IE00B7SZLL34.SGD","LU2272731782.SGD","DULL","FLOT","LU2054465674.USD","SG9999018865.SGD","LU1674673428.USD","LU1718418525.SGD","LU0320765489.SGD","LU0476273544.USD","LU0310799852.SGD","LU0820561818.USD","TRFK","AAAU","IGV","LU2322448791.USD","LU2095319765.USD","LU0784384876.USD","DZZ","LU2463028550.USD","LU2552382132.HKD","SMHU","LU1670710588.SGD","LU2023250330.USD","LU2931357623.SGD","LU1564329628.SGD","LU1979441026.SGD","LU1496350502.SGD","LU1548497426.USD","LU1244550577.SGD","GLDY","SG9999001424.SGD","LU2381873111.SGD","SH","IE00BLSP4239.USD","BERZ","IE0001KFT4U8.USD","LU1242518857.USD","LU1064131342.USD","LU1670710661.SGD","BK4528","IVV","LU1084165304.USD","LU1232071149.USD","LU2023250504.SGD","IE00B19Z9505.USD","BK4575","QQH","LU0203345920.USD","BK4566","LU1935043452.HKD","LU0878866978.SGD","CWB","GDXY","IE000KEQY171.SGD","LU1804176565.USD","LU2290526834.HKD","SPXS","LU0061474705.USD","FBYY","LU1035773651.USD","LU1642822529.SGD","SSG","DRIV","LU1201861249.SGD","LU1815333072.USD","BK4532","SG9999001077.SGD","XSD","BK7504","TDV","LU1066051498.USD","IE00B4YYXB79.USD","IE0004445239.USD","AGQ","SPYM","LU1868836914.USD","LU0321505439.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670942717","title":"Novo Nordisk (0QIU) Receives a Hold from Bank of America Securities","url":"https://stock-news.laohu8.com/highlight/detail?id=2670942717","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670942717?lang=en_us&edition=fundamental","pubTime":"2026-09-26 06:45","pubTimestamp":1790376314,"startTime":"0","endTime":"0","summary":"In a report released today, Sachin Jain from Bank of America Securities reiterated a Hold rating on Novo Nordisk, with a price target of DKK350.00....","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/novo-nordisk-0qiu-receives-a-hold-from-bank-of-america-securities-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/novo-nordisk-0qiu-receives-a-hold-from-bank-of-america-securities-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0154236417.USD","OZEM","BK4588","IE00BKVL7J92.USD","BK4532","LU1093756168.USD","NVO","BK4007","IE00BZ1G4Q59.USD","NVOX","PPH","BK4599","BK4585","NVOH","LU1093756325.SGD","NVOC","THNR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1129613388","title":"Novo Bets on Next Chapter While Eli Lilly Extends Its GLP-1 Dominance","url":"https://stock-news.laohu8.com/highlight/detail?id=1129613388","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1129613388?lang=en_us&edition=fundamental","pubTime":"2026-09-25 19:51","pubTimestamp":1790337115,"startTime":"0","endTime":"0","summary":"Novo Nordisk this week unveiled an ambitious strategy aimed at reigniting growth beyond its flagship injections Wegovy and Ozempic, but the road back to winning investors and reclaiming share in the...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0225283273.USD","LLII","LU1057294990.SGD","LU1548497426.USD","LU2471134796.USD","SG9999014880.SGD","LU0256863811.USD","SGXZ99366536.SGD","BK4533","LU2211815571.USD","BK4007","PPH","LU2023250504.SGD","RXL","LU1988902786.USD","LU1069344957.HKD","LU2236285917.USD","SG9999018857.SGD","LU2468319806.SGD","LU2552382215.SGD","LU1629891620.HKD","IE00BKPKM429.USD","IE00B1BXHZ80.USD","LU1712237335.SGD","LU1814569148.SGD","SG9999015945.SGD","LU1145028129.USD","LU1366192091.USD","WDNA","LU2491049909.HKD","LU1868837136.USD","SG9999015986.USD","TRUH","IE00BFSS7M15.SGD","LU2750360997.AUD","MEDX","LU1035775433.USD","LU1868836914.USD","CANC","OZEM","LU0417517546.SGD","LU0238689110.USD","IE00BJT1NW94.SGD","LU0210536198.USD","LU0432979614.USD","LU0471298777.SGD","LU0385154629.USD","LU0882574055.USD","LU1280957306.USD","LU2361044949.HKD","MEDI","LU0106261372.USD","BK4585","IE0009355771.USD","LU0820561909.HKD","THNR","LU1989771016.USD","MHIP","SG9999017495.SGD","IE00BWXC8680.SGD","LU1023059063.AUD","LU1061106388.HKD","FTXH","SG9999013999.USD","LU2746668461.USD","SGXZ81514606.USD","LU0158827781.USD","LU2491050154.USD","LU0345770308.USD","LU0353189680.USD","IE0005OL40V9.USD","IE00B7KXQ091.USD","LU2023250330.USD","LU0820562030.AUD","LU0234572021.USD","LU0058720904.USD","ILDR","TMED","LU0471298694.HKD","LU2750360641.GBP","SGXZ51526630.SGD","LU0466842654.USD","LU0820561818.USD","LU2237443549.SGD","BK4534","NVOC","LU0203201768.USD","SG9999014898.SGD","LU2471134879.HKD","LU0823434583.USD","LU0672654240.SGD","LU2112291526.USD","LU2023251221.USD","LU2168564065.EUR","LU0289739699.SGD","LU2357305700.SGD","LU2360106947.USD","LU2168564495.EUR","IXJ","VHT","LU0823416689.USD","LU0354030511.USD","LU1093756168.USD","LU0154236417.USD","LU0787776722.HKD","GB00BDT5M118.USD","IE0004445239.USD","LU2089283258.USD","LU0079474960.USD","LU2462157665.USD","LU0109391861.USD","SG9999015978.USD","LLY","LU0198837287.USD","LU0354030438.USD","LU1064131342.USD","LU0882574139.USD","IE0001KFT4U8.USD","IE00BJJMRZ35.SGD","LU1267930730.SGD","LU1868837300.USD","SGXZ31699556.SGD","LLYZ","LU1623119135.USD","IE00BK4W5L77.USD","LU0320765992.SGD","BK4532","LU2265009873.SGD","GDOC","LU0708995401.HKD","LU0456855351.SGD","LU0889565916.HKD","SG9999014906.USD","AGNG","IE00B775H168.HKD","LU2271345857.HKD","LU0158827948.USD","LU2602419157.SGD","IE00BKDWB100.SGD","LU1232071149.USD","NVOH","IE00BJJMRX11.SGD","CURE","LU0683600562.USD","LU1720051017.SGD","SG9999014914.USD","BK4599","LU2106854487.HKD","IE00B1XK9C88.USD","LU1974910355.USD","IYH","BK4588","LU0640476718.USD","LU2237443978.SGD","NVO","LU2471134523.USD","LU2108987350.USD","LU1868836591.USD","IE00B4JS1V06.HKD","LU2417539215.USD","IE00BZ1G4Q59.USD","LU0786609619.USD","LU2462591350.SGD","LU0943347566.SGD","LU2361044865.SGD","NVOX","SG9999001176.USD","PJP","XLV","LU0256863902.USD","LU2324357040.USD","LU0006306889.USD","LU0689472784.USD","LU1691799644.USD","LU1720051108.HKD","LU1868836757.USD","IE00BK4W5M84.HKD","LU2168564222.USD","SG9999015952.SGD","ELIL","IE00BJLML261.HKD","LU2168563687.JPY","LU2237443382.USD","IHE","LU2896262040.SGD","LU1979441026.SGD","LU0353189763.USD","LU1291159041.SGD","LU2111349929.HKD","LU2237438978.USD","ELIS","LU1551013342.USD","LU0320765059.SGD","IE00B4R5TH58.HKD","LU1804176565.USD","LU1093756325.SGD","LU0109394709.USD","IE00BN29S564.USD","LU0203202063.USD","LU0323591593.USD","LU2168564149.EUR","LU2089284900.SGD","LU1127390331.HKD","HRTS","LU0964807845.USD","LU2237443895.HKD","LU2746668974.SGD","LU2063271972.USD","IE00B2B36J28.USD","IE0004445015.USD","LU0316494557.USD","SG9999018865.SGD","LU2089984988.USD","LU2552382058.USD","LU1551013425.SGD","IE00BFTCPJ56.SGD","LU2237443465.HKD","LLYX","LU0133085943.USD","IE00BFSS8Q28.SGD","LU1983299246.USD","LU2461242641.AUD","LU2213496289.HKD","LU0094547139.USD","IE0002141913.USD","SGXZ57979304.SGD","IE00BKVL7J92.USD","LU0823434740.USD","LU2471134952.CNY","LU2756315664.SGD","LU2756315318.SGD","LU0266013472.USD","BK4581","LU0174119429.USD","LU1917777945.USD","LU2028103732.USD","LU2264538146.SGD","FHLC","SG9999001176.SGD","LU2456880835.USD","LU2087625088.SGD","LU2237443622.USD","LU0345770993.USD","LU2361045086.USD","JDOC","LU0061475181.USD","BK4516","LU0096364046.USD","LU2491050071.SGD","LU2552382132.HKD","LU0097036916.USD","LU0114720955.EUR","LU0122379950.USD","IE00BJJMRY28.SGD","LU1323610961.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670494824","title":"After Capital-Markets Day Flop, Novo Strikes Licensing Deal That Sends a Swedish Company's Stock Soaring","url":"https://stock-news.laohu8.com/highlight/detail?id=2670494824","media":"Dow Jones","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670494824?lang=en_us&edition=fundamental","pubTime":"2026-09-25 17:11","pubTimestamp":1790327460,"startTime":"0","endTime":"0","summary":"Novo Nordisk struck a licensing deal with a Swedish company worth over $1 billion.Just days after a capital-markets day left investors wondering what's next for Novo Nordisk, the Danish drug giant struck a licensing deal worth over $1 billion.The deal announced on Thursday give Novo a global exclusive license to a drug-delivery technology platform from Sweden's Nanexa for certain therapeutic peptide drugs in medical conditions including obesity, type 2 diabetes and other cardiometabolic diseases.Novo is the company behind blockbuster diabetes and weight-loss drugs Ozempic and Wegovy, but investors are concerned that its next-generation products are lacking.Nanexa is eligible to receive upfront consideration and potential milestone payments totaling up to EUR1.17 billion , including EUR615 million in upfront payment and development and regulatory milestones. In addition, the agreement provides for low single-digit royalties on future product sales.The news sent the Swedish company  , wh","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NVOC","BK4007","LU0154236417.USD","OZEM","LU1093756168.USD","NVOX","THNR","BK4599","IE00BZ1G4Q59.USD","NRNVF","BK4585","BK4588","LU1093756325.SGD","BK4532","PPH","NVO","NVOH","IE00BKVL7J92.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670445217","title":"Novo Nordisk Licenses Nanexa Drug Delivery Technology","url":"https://stock-news.laohu8.com/highlight/detail?id=2670445217","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670445217?lang=en_us&edition=fundamental","pubTime":"2026-09-25 15:46","pubTimestamp":1790322401,"startTime":"0","endTime":"0","summary":"Novo Nordisk  agreed to a global exclusive license with Nanexa to use the latter's PharmaShell drug delivery technology in up to five development programs targeting obesity, type 2 diabetes and other cardiometabolic conditions, Nanexa said Thursday.The companies will develop long-acting injectable formulations with target dosing schedules of once monthly or once quarterly, Nanexa saidThe company said it is eligible for up to 1.17 billion euros  in total payments, including 615 million euros in upfront and development and regulatory milestones.The remaining payments are tied to sales milestones, Nanexa said, adding it will also receive low-single-digit royalties on global net sales of products developed under the agreement.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0154236417.USD","OZEM","BK4588","IE00BKVL7J92.USD","BK4532","LU1093756168.USD","NVO","BK4007","IE00BZ1G4Q59.USD","NVOX","PPH","BK4599","BK4585","NVOH","LU1093756325.SGD","NVOC","THNR"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2670490065","title":"Cboe data shows mixed options sentiment in Novo Nordisk with shares up 0.96%","url":"https://stock-news.laohu8.com/highlight/detail?id=2670490065","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670490065?lang=en_us&edition=fundamental","pubTime":"2026-09-25 03:55","pubTimestamp":1790279714,"startTime":"0","endTime":"0","summary":"Cboe data shows mixed options sentiment in Novo Nordisk (NVO), with shares up 36c, or 0.96%, near $38.53. Options volume more than double the daily...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/cboe-data-shows-mixed-options-sentiment-in-novo-nordisk-with-shares-up-0-96-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/cboe-data-shows-mixed-options-sentiment-in-novo-nordisk-with-shares-up-0-96-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","BK4532","NVOX","OZEM","NVO","BK4585","IE00BKVL7J92.USD","NVOC","PPH","THNR","BK4599","BK4007","NVOH","LU0154236417.USD","LU1093756325.SGD","LU1093756168.USD","IE00BZ1G4Q59.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":2,"totalSize":200,"code":"91000000","status":"200"}]}}